Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence

ClinicalTrials.gov ID: NCT03052764

Public ClinicalTrials.gov record NCT03052764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence (LO-BOT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of onabotulinumtoxinA 100 U (BOTOX®), compared to placebo, when injected into the bladder using an alternative injection paradigm in reducing the number of daily urinary incontinence episodes in patients with overactive bladder (OAB) and urinary incontinence whose symptoms have not been adequately managed with an anticholinergic.

Study identification

NCT ID
NCT03052764
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Allergan
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 11, 2016
Primary completion
Dec 9, 2018
Completion
Dec 9, 2018
Last update posted
Dec 23, 2019

2016 – 2018

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
Orange County Urology Associates Laguna Hills California 92653
Tower Urology Los Angeles California 90048
University of California, Irvine Medical Center Orange California 92868
Genitourinary Surgical Consultants Denver Colorado 80220
East Coast Institute for Research, LLC Jacksonville Florida 32204
PMG Research of Christie Clinic Champaign Illinois 81820
Deaconess Clinic, Inc. Evansville Indiana 47113
Women's Health Advantage Fort Wayne Indiana 46825
Urogynecology Associates Indianapolis Indiana 46062
Urology of Indiana Noblesville Indiana 46062
Iowa Clinic West Des Moines Iowa 50266
Regional Urology Shreveport Louisiana 71106
Chesapeake Urology Owings Mills Maryland 21117
Beyer Research Kalamazoo Michigan 49009
Michigan Institute of Urology, P.C. Troy Michigan 48084
Adult and Pediatric Urology Omaha Nebraska 68114
Premier Urology LLC Edison New Jersey 08837
Western New York Urology Associates Cheektowaga New York 14225
Manhattan Medical Research New York New York 10016
Advanced Urology Centers of NY A division of IMP Plainview New York 11803
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601
Alliance Urology Specialists Greensboro North Carolina 27403
Sandhills Medical Center Hamlet North Carolina 28345
PMG Research of Wilmington Wilmington North Carolina 28401
Urologic Consultants of Southeastern Pennsylvania Bala-Cynwyd Pennsylvania 19004
Center for Pelvic Health Franklin Tennessee 37067
Urology Clinics of North Texas Dallas Texas 75231
Virginia Urology Richmond Virginia 23230
Virginia Urology Center Richmond Virginia 23235
Urology of Virginia Virginia Beach Virginia 23462
Integrity Medical Research, LLC Mountlake Terrace Washington 98043

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03052764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2019 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03052764 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →